Chronic prostatitis
Conditions
Interventions
Experimental Group:Detoxifying and Promoting Circulation Suppository + Tamsulosin Hydrochloride Controlled-Release Capsules / Levofloxacin Tablets
Control Group:Detoxifying and dredging suppository simulator + Tamsulosin hydrochloride controlled-release capsule / Levofloxacin tablets
Sponsors
Henan Provincial Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Meets the Western diagnostic criteria for Type III prostatitis; (2) Meets the TCM diagnostic criteria for damp-heat obstruction syndrome; (3) Male patients with a disease duration of over 3 months and aged between 18 and 50 years old; (4) NIH-CPSI total score ranges from 15 to 43 points; (5) Able to accept prostate palpation and willing to provide prostate fluid; (6) No use of medications for this condition or drugs with similar efficacy to the study drug in the past month; (7) After being informed of the, agrees to participate in the clinical study and voluntarily signs the informed consent form. Only those who meet all seven criteria above can be included in the study; otherwise, they will not be included.
Exclusion criteria
Exclusion criteria: (1) History of urinary tract infections, tuberculosis, stones, orchitis, varicocele, prostate tumors, or other urological or reproductive system diseases that may affect the study within the past 3 months; (2) Severe cardiovascular diseases, cerebrovascular diseases, hepatic or renal insufficiency, congenital diseases, malignant tumors, hypotension, or mental disorders; (3) History of surgery within the past 3 months; (4) History of allergy to treatment drugs, allergic constitution, or inability to tolerate medications; (5) Plans for pregnancy during medication or within 1 month after medication; (6) Participation in other clinical studies within the past 3 months prior to the study. Subjects meeting any of the above six criteria will be excluded and not included in the scope of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NIH-CPSI Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM symptom score;Expressed Prostatic Secretion White Blood Cell Count?;In Expressed Prostatic Secretions, Tumor Necrosis Factor-alpha levels;The level of Interleukin-6 in Expressed Prostatic Secretions;The level of Interleukin-1ß in Expressed Prostatic Secretions;The level of Interleukin-10 in Expressed Prostatic Secretions; | — |
Countries
China
Contacts
Public ContactSun Zixue
Henan Provincial Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Henan University of Traditional Chinese Medicine)
Outcome results
None listed